Directors of the California stem cell agency plan to continue their review of key portions of the grant approval process, including the appeals that have been something of a bugaboo for both applicants and directors.
Don Gibbons, chief communications officer for CIRM, said in an email that the directors' Science Subcommittee on Tuesday concluded that “they need to devote a large chunk of a future committee meeting to just this issue.”
No further details were immediately known although a transcript of the meeting should be available in about 10 days. We will carry a fresh article on the subject at that point.
This is a matter that all California stem cell scientists should pay special attention to. It could have a significant impact on their livelihood.
For more details on the scope of the directors' concern, see this rundown on related documents.
No comments:
Post a Comment